These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9498632

  • 21. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
    Mertens I, Ballaux D, Funahashi T, Matsuzawa Y, Van der Planken M, Verrijken A, Ruige JB, Van Gaal LF.
    Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
    [Abstract] [Full Text] [Related]

  • 22. Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss.
    Kockx M, Leenen R, Seidell J, Princen HM, Kooistra T.
    Thromb Haemost; 1999 Nov; 82(5):1490-6. PubMed ID: 10595643
    [Abstract] [Full Text] [Related]

  • 23. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS.
    N Engl J Med; 2004 Jun 17; 350(25):2549-57. PubMed ID: 15201411
    [Abstract] [Full Text] [Related]

  • 24. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.
    Kolak M, Westerbacka J, Velagapudi VR, Wågsäter D, Yetukuri L, Makkonen J, Rissanen A, Häkkinen AM, Lindell M, Bergholm R, Hamsten A, Eriksson P, Fisher RM, Oresic M, Yki-Järvinen H.
    Diabetes; 2007 Aug 17; 56(8):1960-8. PubMed ID: 17620421
    [Abstract] [Full Text] [Related]

  • 25. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 17; 89(6):381-4. PubMed ID: 19567114
    [Abstract] [Full Text] [Related]

  • 26. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
    Goral J.
    Ann Acad Med Stetin; 2008 Feb 17; 54(2):14-21. PubMed ID: 19374226
    [Abstract] [Full Text] [Related]

  • 27. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
    Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang Y, Li P.
    Clin Chim Acta; 2006 Aug 17; 370(1-2):57-62. PubMed ID: 16507303
    [Abstract] [Full Text] [Related]

  • 28. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
    He G, Pedersen SB, Bruun JM, Lihn AS, Richelsen B.
    Horm Metab Res; 2003 Jan 17; 35(1):18-23. PubMed ID: 12669266
    [Abstract] [Full Text] [Related]

  • 29. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE, Ermetici F, Cereda E, Coman C, Locati M, Morricone L, Corsi MM, Ambrosi B.
    Nutr Metab Cardiovasc Dis; 2008 Oct 17; 18(8):523-30. PubMed ID: 18083357
    [Abstract] [Full Text] [Related]

  • 30. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
    Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M.
    Sci Transl Med; 2010 Feb 24; 2(20):20ra15. PubMed ID: 20371491
    [Abstract] [Full Text] [Related]

  • 31. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.
    Int J Obes (Lond); 2006 Jun 24; 30(6):877-83. PubMed ID: 16418758
    [Abstract] [Full Text] [Related]

  • 32. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):688-94. PubMed ID: 12615670
    [Abstract] [Full Text] [Related]

  • 33. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N.
    Clin Endocrinol (Oxf); 2005 May 01; 62(5):607-10. PubMed ID: 15853833
    [Abstract] [Full Text] [Related]

  • 34. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
    Zhao SP, Li J, Xu Z, Wu J, Li Q, Ye H.
    Clin Chim Acta; 2004 Nov 01; 349(1-2):81-6. PubMed ID: 15469859
    [Abstract] [Full Text] [Related]

  • 35. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.
    Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Blüher M, Kiess W, Körner A.
    Int J Pediatr Obes; 2011 Jun 01; 6(2-2):e345-52. PubMed ID: 20950077
    [Abstract] [Full Text] [Related]

  • 36. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue.
    Ekström M, Liska J, Eriksson P, Sverremark-Ekström E, Tornvall P.
    Thromb Haemost; 2012 Sep 01; 108(3):485-92. PubMed ID: 22740034
    [Abstract] [Full Text] [Related]

  • 37. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T, Hauner H.
    Int J Obes Relat Metab Disord; 2004 Nov 01; 28(11):1357-64. PubMed ID: 15356668
    [Abstract] [Full Text] [Related]

  • 38. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
    Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM.
    J Clin Endocrinol Metab; 1999 Nov 01; 84(11):4097-105. PubMed ID: 10566656
    [Abstract] [Full Text] [Related]

  • 39. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
    Nordt TK, Bode C, Sobel BE.
    Diabetologia; 2001 Sep 01; 44(9):1121-4. PubMed ID: 11596666
    [Abstract] [Full Text] [Related]

  • 40. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
    Koistinen HA, Dusserre E, Ebeling P, Vallier P, Koivisto VA, Vidal H.
    Diabetes Metab Res Rev; 2000 Sep 01; 16(5):364-9. PubMed ID: 11025560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.